Skip to main content
Univo Pharmaceuticals Ltd. logo

Univo Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · UNVO-M ISIN · IL0010935588 TA Manufacturing
Open in API
Filings indexed 4 across all filing types
Latest filing 2023-08-10 Delisting Announcement
Country IL Israel
Listing TA UNVO-M

About Univo Pharmaceuticals Ltd.

https://www.univopharma.com

Univo Pharmaceuticals Ltd. is a vertically-integrated biopharmaceutical company specializing in medical cannabis. The company's operations cover the entire value chain, from research, development, and cultivation to manufacturing and distribution of cannabis-based medicinal products. Univo develops a wide range of products designed to meet patient needs, which are supplied to the medical sector and pharmacies. The company is also engaged in developing new therapeutic solutions and drugs, with a focus on treatments for the central nervous system (CNS).

Recent filings

Filing Released Lang Actions
ISA informed TASE that the company is a "shell company", the company's securities will be transferred to the maintenance list on Sunday, August 13, 2023 (The suspension of trading in them will continu
Delisting Announcement Classification · 95% confidence The document is an official notice from the Tel Aviv Stock Exchange (TASE) regarding the trading status of UNIVO PHARMACEUTICALS LTD's shares and convertible bonds. It details the suspension of trading, transfer to the maintenance list, sector reclassification, and conditions for potential de-listing. The content is regulatory in nature, announcing changes in listing and trading status rather than providing financial data, management discussion, or detailed reports. The document length is short (2209 characters) and it serves as an announcement rather than a full report. Therefore, it fits best under the category of a Delisting Announcement (DLST).
2023-08-10 Hebrew (modern)
Trading in the company's shares has been suspended as of today, on December 28 ,2022, the Board of Directors will discuss the continuation of the suspension of trading.
Delisting Announcement Classification · 95% confidence The document is a notice addressed to members of the Tel Aviv Stock Exchange (TASE) regarding the suspension of trading in the shares and bonds of UNIVO PHARMACEUTICALS LTD due to insolvency and the appointment of temporary receivers. It discusses the suspension of trading, potential delisting conditions, and invites public comments on the suspension. The content is regulatory in nature, announcing trading suspension and potential delisting, but does not contain financial statements, audit information, or detailed financial data. The document is short (1580 characters) and serves as an official announcement about trading suspension and possible delisting rather than a full report or financial filing. Therefore, the most appropriate classification is a Delisting Announcement (DLST).
2022-12-18 Hebrew (modern)
BOND SERIES A-TRADING SUSPENSION FOLLOWING TRUSTEE ANNOUNCEMENT REGARDING IMMEDIATE PAYMENT
Regulatory Filings Classification · 95% confidence The document is a short announcement addressed to TASE members regarding the suspension of trading in a specific bond series following a trustee announcement about immediate payment. It is brief (453 characters) and does not contain financial statements or detailed financial data. It is an official regulatory announcement related to trading status and compliance, not a full report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2022-12-12 Hebrew (modern)
Discontinuation of Market Making, If another market maker will not start to operate as a market maker the security will be added to the illiquid securities list from 11 August 2022
Regulatory Filings Classification · 95% confidence The document is a notification from the Tel Aviv Stock Exchange about the discontinuation of market making for a specific security (UNIVO). It states that if no new market maker operates, the security will be added to the illiquid securities list. This is an official announcement related to trading status and market making activities, not a financial report, earnings release, or management information. It is a regulatory announcement about market operations and security status. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-07-21 Hebrew (modern)

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.